Skip to content
Medical Health Aged Care

Andersen Consulting Enters Collaboration Agreement with Solutia

Andersen Consulting 2 mins read
SAN FRANCISCO--BUSINESS WIRE--

Andersen Consulting expands its presence in Spain through a Collaboration Agreement with Solutia, a firm specializing in occupational and workplace health solutions, as well as recruitment across the life sciences and healthcare sectors.

Founded in 2014, Solutia provides comprehensive services and consulting focused on healthy work environments, absenteeism, healthcare outsourcing, and training for organizations across all sectors. The firm also delivers recruitment and executive search solutions specialized in life sciences, technical professionals, and middle and executive management, with deep expertise in the pharmaceutical, biotechnology, medical technology, and healthcare industries. Solutia helps organizations enhance workforce efficiency and attract specialized talent through tailored solutions based on data.

“We are committed to advancing how organizations attract, develop, and manage talent in an increasingly complex environment,” said Cesar Castel, managing director of Solutia. “Collaborating with Andersen Consulting allows us to bring our specialized expertise into a broader strategic and digital context, delivering holistic solutions that accelerate sustainable growth for our clients.”

“Solutia brings deep industry expertise and a reputation for excellence in solutions that enhance organizational health and the scientific development,” added Mark L. Vorsatz, global chairman and CEO of Andersen. “Their capabilities perfectly complement Andersen Consulting’s multidisciplinary platform, enabling us to jointly help clients optimize operations, strengthen compliance, and drive transformation.”

Andersen Consulting is a global consulting practice providing a comprehensive suite of services spanning corporate strategy, business, technology, and AI transformation, as well as human capital solutions. Andersen Consulting integrates with the multidimensional service model of Andersen Global, delivering world-class consulting, tax, legal, valuation, global mobility, and advisory expertise on a global platform with more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms. Andersen Consulting Holdings LP is a limited partnership and provides consulting solutions through its member firms and collaborating firms around the world.


Contact details:

[email protected]

More from this category

  • Medical Health Aged Care
  • 06/07/2026
  • 23:18
Shilpa Medicare Limited

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

DHARWAD, India–BUSINESS WIRE– Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement…

  • Contains:
  • Medical Health Aged Care
  • 06/07/2026
  • 21:47
Agenus Inc.

Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026

Fully enrolled 123-patient Phase 1b cohort demonstrated 21.2-month median overall survival, 33% three-year overall survival, and a survival curve plateau beyond two years Data…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 06/07/2026
  • 15:16
Brandon Capital

Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics

Melbourne, Australia, 6 July 2026- Brandon Capital, Australasia’s leading life sciences venture capital firm, todayannouncesthe successful exit of its portfolio company Myricx Bio following its agreement to be acquired by Novartis.The transaction is valued at up to US$1.5 billion (~A$2.16bn) including an upfront cash payment of US$1.1 billion (~A$1.58bn) plus potential milestone payments. Myricx Biois a UK-based pre-clinical oncology company developing a novel class of payloads for antibody-drug conjugates (ADCs). One of the most important emerging modalities in cancer therapy, ADCs combine the targeting precision of antibodies with the tumour-killing activity of potent small-molecule payloads. The acquisition advances ADC innovation…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.